MedPath

Lifestyle Intervention in Obstructive Sleep Apnoea

Phase 2
Completed
Conditions
Obstructive Sleep Apnoea
Obesity
Interventions
Behavioral: Combined lifestyle intervention
Registration Number
NCT01546792
Lead Sponsor
Sheffield Teaching Hospitals NHS Foundation Trust
Brief Summary

Obstructive sleep apnoea/hypopnoea syndrome (OSAHS) is a common disorder characterised by interrupted breathing while sleeping. It is associated with cardiovascular problems such as high blood pressure, heart attack and stroke. Furthermore, most patients with OSAHS are overweight and have impaired quality of life. Lifestyle interventions incorporating exercise training, dietary advice and behaviour change have been shown to elicit favourable changes in quality of life, body mass/composition and cardiovascular risk in a range of patient groups. However, no study has investigated the impact of lifestyle modification on such health outcomes in patients with OSAHS. This study will address this issue by investigating the effects of a lifestyle intervention on quality of life, body mass/composition and cardiovascular risk in patients with OSAHS. A total of 60 volunteers will be recruited and randomly allocated to one of the two groups. Patients in the intervention group will be offered a 12-week individualised lifestyle programme consisting of supervised exercise training, dietary advice and behaviour change counselling. Patients in the control group will receive an educational booklet detailing healthy eating and exercise guidelines but no supervised or structured intervention. The results of this study will inform the design of a larger, multi-centre randomised controlled trial.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
60
Inclusion Criteria
  • obstructive sleep apnoea patients who have been receiving CPAP therapy for at least 6 months and are known to be adherent to the treatment (>75% nightly use per week)
  • clinically obese (body mass index >30)
  • age 18-85 years
  • able to undertake exercise testing and training
Exclusion Criteria
  • patients with any contraindications to exercise (e.g. severe hypertension, unstable arrhythmias, severe musculoskeletal injuries)
  • unable to undertake the requirements of the study
  • non-English speaking
  • already undertaking >30 min exercise >3 times per week
  • non-compliant with CPAP
  • body mass index <30
  • unable to provide written informed consent

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Lifestyle interventionCombined lifestyle interventionExercise training (mixture of supervised and non-supervised) Dietary advice Behaviour change counselling (physical activity, diet)
Primary Outcome Measures
NameTimeMethod
Incremental shuttle walk performance25 weeks
Body mass25 weeks
Secondary Outcome Measures
NameTimeMethod
Quality of life (EQ-5D and EQ-VAS)13 and 25 weeks
Body fat percentage13 and 25 weeks
Resting blood pressure13 and 25 weeks
Blood markers (glucose, insulin, lipids, CRP)13 and 25 weeks

Trial Locations

Locations (2)

Pulmonary Function Unit, Northern General Hospital

🇬🇧

Sheffield, South Yorkshire, United Kingdom

Centre for Sport and Exercise Science, Sheffield Hallam University

🇬🇧

Sheffield, South Yorkshire, United Kingdom

© Copyright 2025. All Rights Reserved by MedPath